跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 41 条关于
“Kedrion”
全部
41
临床试验
15
药物
7
机构
4
资讯
15
11个月前
Kedrion Biopharma Secures FDA Approval for QIVIGY, First Proprietary IVIG Therapy for Primary Immunodeficiency
9个月前
EMA Grants Orphan Drug Designation to Kedrion's Ceruloplasmin Treatment for Rare Iron Metabolism Disorder
去年
FDA Approves Kedrion's Facility for RYPLAZIM® Production, Expanding Access to PLGD-1 Treatment
去年
FDA Approves Kedrion's Facility for RYPLAZIM Production, Expanding Access for PLGD-1 Patients
去年
FDA Approves Kedrion's Bolognana Facility for RYPLAZIM Production, Expanding Access to PLGD-1 Treatment
去年
FDA Approves Kedrion's Facility for RYPLAZIM Production, Expanding Access to PLGD-1 Treatment
去年
FDA Grants Orphan Drug Designation to COAGADEX for Rare Bleeding Disorder Associated with AL Amyloidosis
去年
Biotest Reports 6% Sales Growth in 2024, FDA Approves Yimmugo for US Market
3个月前
Kamada Receives FDA Approval for In-House Rabies Virus Neutralization Testing Laboratory
去年
Medrio Unveils Enhanced RTSM Solution to Accelerate Clinical Trial Implementation
第 1 页,共 2 页
上一页
下一页